Abstract Ibuprofen is the third most consumed pharmaceutical drug in the world. Several isolates have been shown to degrade ibuprofen, but very little is known about the biochemistry of this process. This study investigates the degradation of ibuprofen by Patulibacter sp. strain I11 by quantitative proteomics using a metabolic labelling strategy. The wholegenome of Patulibacter sp. strain I11 was sequenced to provide a species-specific protein platform for optimal protein identification. The bacterial proteomes of actively ibuprofen-degrading cells and cells grown in the absence of ibuprofen was identified and quantified by gel based shotgun-proteomics. In total 251 unique proteins were quantitated using this approach. Biological process and pathway analysis indicated a number of proteins that were up-regulated in response to active degradation of ibuprofen, some of them are known to be involved in the degradation of aromatic compounds. Data analysis revealed that several of these proteins are likely involved in ibuprofen degradation by Patulibacter sp. strain I11.
Introduction
The emergence of pharmaceutically active compounds (PhACs) in natural matrices such as soil, sediments and water has been an issue of increasing concern in recent years. Several studies have been carried out to elucidate the magnitude of the risks that PhACs may impose to the environment and health of living beings (Daughton and Ternes 1999; Pal et al. 2010; Murray et al. 2010; Santos et al. 2010) . Many PhACs are potentially harmful to the environment and the public health, and several PhACs are considered to have mutagenic, carcinogenic and endocrine disruptor effects (Daughton and Ternes 1999; Pal et al. 2010; Kummerer 2009; Santos et al. 2010) . Other compounds appear harmless when considered individually, but a potential risk of unknown additive or synergistic effects in the presence of mixtures of compounds may exist. Presence of PhACs in the environment suggests their inefficient removal in wastewater treatment plants (WWTP) . PhACs can typically be detected in the ng/L to lg/L range in influents and have highly varying removal degrees in wastewater treatment (Heberer 2002; Kolpin et al. 2002; Onesios et al. 2009; Daughton and Ternes 1999; Salgado et al. 2010 Salgado et al. , 2011 Santos et al. 2010) .
Elimination of organic contaminants and some micropollutants from wastewater treatment is due to the action of different removal mechanisms, such as sorption, biodegradation and abiotic degradation (Salgado et al. 2012) . Removal of polar acidic pharmaceuticals seems to be predominantly removed by microbial degradation in wastewater treatment systems (Salgado et al. 2012; Quintana et al. 2005) .
Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) detected in the ng to lg per litre range in wastewater, as shown by numerous surveys that have been carried out all over the world (Daughton and Ternes 1999; Kolpin et al. 2002; Onesios et al. 2009; Salgado et al. 2010 Salgado et al. , 2011 Salgado et al. , 2012 Ying et al. 2009 ). Ibuprofen is globally the third most produced pharmaceutical compound and a highly diffuse consumption makes it one of the most frequently detected compounds in wastewater (Buser et al. 1999) . Typical values of ibuprofen detection range from 22 to 84 lg/L in raw sewage and treated effluent water, respectively, while upto 5 lg/L has been detected in surface waters (Santos et al. 2010; Pal et al. 2010) .
Only few studies have focused on the biochemistry of the biodegradation of PhACs. Studies on the biodegradation of ibuprofen in activated sludge have suggested the formation of hydroxy-ibuprofen, carboxy-ibuprofen, and carboxy-hydratropic acid (carboxy-HA) as degradation products (Quintana et al. 2005; Buser et al. 1999; Zwiener et al. 2002; Zwiener and Frimmel 2003; Winkler et al. 2001) . Genetic and metabolite analysis of ibuprofen degradation by Sphingomonas Ibu-2, revealed several key metabolites possibly associated with ibuprofen degradation, such as ibuprofen CoA; 1,2-cis-diol-2-hydroibuprofen CoA and 4-isobutylcatechol-and a cluster of five putative genes (ipfABDEF) was used to propose a degradation pathway for ibuprofen by this isolate (Murdoch and Hay 2005; Kagle et al. 2009 ). This approach has provided insights that are potentially of great significance for the understanding of ibuprofen microbial degradation. However, it remains to be elucidated if phylogenetically different microorganisms as well as the strain Sphingomonas Ibu-2 do in fact degrade ibuprofen through this proposed pathway or by some other unknown mechanism.
Quantitative proteomics has proven to be a valuable tool for analysing the physiological response of microorganisms in the presence of specific compounds or under the influence of different physico-chemical parameters (Kim et al. 2009 (Kim et al. , 2007 . Proteomics has also been successfully applied for studying the biodegradation of aromatic hydrocarbons such as benzoate, aniline, and phenol by several microorganisms, e.g. Acinetobacter (Giuffrida et al. 2001; Park et al. 2006; Pessione et al. 2003) and Pseudomonas strains (Loh and Cao 2008) , as well as several mycobacterial (Kim et al. 2004; Liang et al. 2006) and rhodococcal species (Navarro-Llorens et al. 2005; Patrauchan et al. 2005; Tomas-Gallardo et al. 2006 ). Many microorganisms capable of degrading micropollutants induce the expression of enzymes involved in the metabolic pathway(s) related to the degradation itself, when grown in the presence of the target compound. These induced proteins can be identified by quantitative comparisons of the proteomes expressed in presence and absence of the micropollutant, which give direct measurement of protein expression levels (Kim et al. 2007 (Kim et al. , 2009 ). Furthermore, proteomics is a powerful tool for providing functional information on prokaryotic gene expression at the protein level essentially allowing for bridging the gap between genome and phenotype.
The main objective of this study was to investigate the degradation pathway of ibuprofen by Patulibacter sp. strain I11, a bacterial strain isolated from activated sludge, using quantitative proteomics combined with genetic information of the microorganism. Global changes in the proteome of Patulibacter sp. strain I11 when grown in the presence and absence of ibuprofen, were characterised by stable isotope metabolic labelling in combination with 1-D gel based shotgunproteomics. To the best of our knowledge, this study is the first proteomic analysis on an ibuprofen-degrading microorganism, providing novel information on the potential proteins related to the degradation of ibuprofen, and represents a step towards a better understanding the conditions that promote the degradation of this NSAID in WWTPs.
Materials and methods

Bacterial isolation and characterization
The bacterial strain I11, used in this study, was isolated from activated sludge collected from Beirolas WWTP (Lisbon, Portugal). Activated sludge (3 g/L) was inoculated in M9 minimal medium (Oehmen et al. 2009 ) supplemented with 500 lg/L of ibuprofen and grown at 28°C for 15 days. Ibuprofen degradation capacity of the enriched microbial community was evaluated during the period of incubation. Ibuprofen was followed by high performance liquid chromatography and regularly added to avoid depletion. I11 was subsequently isolated from this microbial enrichment by a series of tenfold dilutions in 0.85 % (w/v) NaCl streaked on agar plates containing minimal medium supplemented with 250 lg/L of ibuprofen and 15 g/L agar. The plates were incubated at 28°C for 3-4 days and individual colonies were selected, re-inoculated onto the same medium supplemented with 1 g/L of yeast extract (Oxoid, Hampshire, England) and tryptone (Oxoid, Hampshire, England) (50 % of each) for isolation into pure cultures. Cells were subjected to ibuprofen biodegradation in OD2-medium (Silantes, München, Germany) and M9 medium supplemented with 1 g/L yeast extract and tryptone in batch experiments at different initial ibuprofen concentrations (1,000, 250 and 50 lg/L). All incubations were aerobic and run at 28°C on a rotary table (110 rpm), and the ibuprofen degradation and OD 600 were measured at regular intervals.
Bacterial cultivation conditions and protein sample preparation for proteomic analysis A differential proteomic approach was carried out by metabolic labelling of the proteome of strain I11 grown in the presence or absence of ibuprofen as outlined in Fig. 1 . Two independent experiments were conducted by metabolically labelling biological replicates using a forward and reverse labelling strategy (Fig. 2) . Precultures of the isolate I11 were aerobically cultured in Erlenmeyer flasks at 28°C, 110 rpm with unlabelled or 15 N-labelled OD2-medium (Silantes, München, Germany). The forward and reverse labelling strategy served the purpose of evaluating potential influence of the 14 N-and 15 N-medium on protein expression levels. 10 mL of pre-culture, grown until mid-logarithmic growth phase (OD 600 * 0.6), was used as inoculum. The forward/reverse labelling experiment was carried out aerobically in 100 mL Erlenmeyer flasks in a total volume of 25 mL of unlabelled and 15 N-labelled OD2-medium, respectively, with or without 65 lg/L of ibuprofen. Cultures were harvested at the mid-logarithmic growth phase (OD 600 * 0.6). Cells were pelleted by centrifugation at 6,0009g for 10 min at 4°C. The supernatant was discarded and the pellet was resuspended in phosphate buffered saline (PBS) supplemented with protease inhibitors (Complete, Mini, EDTA-free Protease Inhibitor Cocktail Tablets; 1 Tablet in 50 mL solution; Boehringer Mannheim, Mannheim, Germany). Cells were subsequently disrupted by sonication (Sonopuls HD2200, Bandelin Electronic, Berlin, Germany) running 10 cycles at 20 W for 1 min, maintaining a 1 min break in-between cycles and keeping samples on ethanol/ice bath. Cell debris was removed by centrifugation at 6,0009g for 10 min at 4°C. The supernatant was collected and centrifuged at 30,0009g for 60 min at 4°C. The supernatant and the pellet (resuspended in 150 lL MilliQ water) constituted the cytosolic and the membrane fraction, respectively. Protein content was determined using the BCA Protein Assay kit (Thermo Fisher Scientific, Rockford, IL), and the 14 N-and 15 Nlabelled samples were mixed in a 1:1 ratio in accordance with the forward/reverse labelling strategy (Fig. 2 ). Samples were subsequently resuspended in SDS-sample buffer containing 40 mM dithiothreitol and denatured at 95°C (5 min), and separated on a 12 % (w/v) SDS-PAGE gel (Bio-Rad, USA). The gel bands were visualized with Coomassie Brilliant Blue staining. Each lane was excised into 16 pieces, and then subjected to in-gel reduction, alkylation, and tryptic digestion as previously described (Shevchenko et al. 2006) . Samples were resuspended in 5 % (w/v) formic acid prior to analysis by tandem mass spectrometry.
Identification and quantification of proteins by NanoFlow-LC-ESI Q-ToF tandem MS Automated LC-ESI MS/MS was performed using a hybrid Q-ToF Mass Spectrometer (Bruker microTOFQ, Biodegradation (2013) 24:615-630 617 Bremen, Germany) and a nano-HPLC system (Agilent 1200; Santa Clara CA, United States) mounted with a single column setup. A reversed phase nanocolumn (15 cm, 75 lm id) was packed in-house with ReproSilPur C18-AQ 3.5 lm resin (Dr. Maisch GmbH, AmmerBuch-Entringen, Germany) using a high-pressure vessel. The sample was loaded with a flow rate of 350 nL/min and subsequently eluted at 200 nL/min using a 35 min gradient of 5-40 % (v/v) acetonitrile in 0.6 % (v/v) acetic acid and 0.005 % (v/v) heptafluorobutyric acid. The mass spectrometer was operated in data dependent acquisition mode to automatically switch between MS and MS/MS acquisition selecting the three most abundant precursor ions. The mass spectrometer was calibrated externally using Tunemix (Agilent G1969-85010) prior to sample acquisition resulting in a sub 5 ppm mass accuracy (R 13.000).
Analysis of proteome data using bioinformatics tools
The MS/MS data was deconvoluted, deisotoped, and exported in a Mascot generic format (mgf-files) prior to database searching. The data were analysed using the MS/MS ion search by the Mascot 2.3 search engine (Matrix Science, UK) against in-house protein database (4,408 sequences; 1,430,678 residues) based on full genome sequencing (isolate I11 whole genome, see below). Protein modifications were fixed for carbamidomethylation of Cys and variable oxidation of Met. The trypsin-derived peptide and peptide fragment mass accuracy were set to 0.05 Da. Results from the automatic database search were evaluated in accordance with the MCP Guidelines (MIAPE) (Taylor et al. 2008 Significance level 0.05; Boundary factor 4; Significance level confidence interval 0.95). Following statistical analysis proteins were gene ontology (GO) categorized using STRAP (Bhatia et al. 2009 ).
RNA isolation and real-time PCR analysis I11 strain was grown under similar conditions to those described earlier for the proteomic labelling. Bacterial cells were harvested at two time points, before spiking the culture with 65 lg/L of ibuprofen (at OD 600 * 0.6) and 1 h after. 5 mL culture from each time point were collected and cells were harvested by centrifugation at 6,0009g for 10 min and immediately frozen by dipping in liquid nitrogen and stored at -80°C. Total RNA was extracted from frozen pellets using the Ribopure Bacterial kit (Ambion) according to the manufacturer's instructions. The RNA was then treated with DNase I (Fermentas) to remove trace amounts of genomic DNA. The RNA quality was checked by running 1 % agarose gel and the concentration was quantified using NanoDrop spectrophotometer (NanoDrop Technologies, USA). The incubations were done in duplicate.
Complementary DNA (cDNA) was synthesized by reverse transcription of equal amounts of total RNA (0.5 lg) from each time point (in total 4) using the AffinityScript qPCR cDNA Synthesis kit (Stratagene) following the kit protocol. Triplicate 25 lL SYBRbased real-time PCR reactions were run containing: 12.9 lL Brilliant III SYBR Green REAL-TIME PCR Master mix (Stratagene), 0.8 lg/lL BSA (New England Biolabs), 900 nM of both forward and reverse primer, 24 nM ROX reference dye (Stratagene), and 5 lL of undiluted cDNA for target genes, or 5 lL of 1:100 dilution for the reference gene. Reactions were run on Mx3005P (Stratagene) 3 min at 95°C, 40 cycles of 30 s at 95°C, 20 s at 60°C, 20 s at 72°C, and finally melting profile analysis. Fluorescence was measured after each annealing step. The specificity of the PCR reactions performed for each run was confirmed by the melting curve analysis and gel electrophoresis. For data analysis, the fold change in expression was calculated for each target gene between the two time points using the CT method (Liu and Saint 2002) as described in detail in (Schmittgen and Livak 2008) . For the normalization of the results, the expression of the 16S rRNA gene was used as an endogenous reference (Talaat et al. 2002; Zhang et al. 2000) . The gene-specific primers used in this study were designed using the GeneFisher (Bielefeld University, Bielefeld, Germany) and synthesized by Invitrogen Life Technologies and are listed in supplementary Table S1 .
Ibuprofen degradation
Samples were taken during the metabolic labelling, centrifuged at 6,0009g for 5 min and the supernatant filtered through a 0.2 lm SPARTAN (Whatman, Dassel, Germany) filter prior to ibuprofen analysis.
The ibuprofen quantification was determined by an ultra-high-speed liquid chromatography system (ACQUITY UPLC System, Waters Chromatography, Milford, MA, USA) equipped with a photodiode array detector and Empower2 data acquisition software (Waters Chromatography). Samples were separated using a reversed phase C18 column (Hibar Purospher STAR RP-18, 3 lM, Merck). Ibuprofen was eluted in isocratic mode, using 50 % (v/v) acetonitrile and 50 % (v/v) of Milli-Q water acidified with 10 mM phosphoric acid, as eluents, for 3.5 min, at 35°C with a constant flow rate of 0.30 mL/min. Ibuprofen was detected at 220 nm and samples were injected twice in a volume of 20 lL. The retention time of the compound (2.9 min) was compared with a standard for identification, and the peak area was used for quantification.
All reagents, acetonitrile (Fisher Scientific, Fair Lawn, USA), phosphoric acid 85 % (Sigma-Aldrich, Germany) and methanol (Fisher Scientific, Fair Lawn, USA), were of HPLC gradient grade, with a purity of C99 %, according to the supplier. Prior to use, solutions were filtered through Whatman filters (Dassel, Germany)-SPARTAN TM (0.2 lm)). The water used in the study was produced by the Milli-Q water system (Millipore, CA, USA). Ibuprofen was obtained from Sigma-Aldrich (Germany).
Bacterial whole-genome sequencing
Library preparation for illumina sequencing DNA was purified from the bacterial isolate I11 cultivated on LB-medium using the UltraClean microbial DNA isolation kit (MoBio, Carlsbad, CA). A library for paired-end sequencing (PE) was prepared from 5 lg of PicoGreen (Invitrogen, UK) quantified DNA using Paired-End Sample Prep Kit (Illumina, CA, USA), according to manufacturer's instructions. Briefly, DNA was fragmented by nebulization to generate fragments \800 bp. The genomic fragments were blunt ended and phosphorylated and a single 'A' nucleotide was added to the 3 0 ends of the fragments. Adapters were ligated to the A-tailed fragments according to the manufacturer's instructions. Size fractionation and purification of ligation products were performed using a 1 % (w/v) agarose gel. Gel slices containing DNA in the 500 bp range were cut, purified and the library enrichment was achieved by using 12 PCR cycles with primers PE1.0 and PE2.0 supplied by the kit manufacturers. Finally, the PE library was purified using QIAquick PCR Purification Kit (Qiagen, Germany) and validated by running 10 % of the product on an agarose gel. The stock was kept at -20°C until used.
Sequencing and de novo genome assembly
The flow cell was prepared according to the manufacturer's instructions using a Paired-End Cluster Generation Kit (Illumina, CA, USA). PE sequencing was performed on an Illumina GAII (Illumina, CA, USA). Five picomolar of the final library was used to achieve approximately 200,000 clusters per tile producing paired-end reads of a 2 9 72 bp in length. Base-calling was performed with the GAPipeline 1.5 using default parameters, which include purity filtering (chastity 0.6). All PE reads were trimmed for length and quality using the CLC Genomics Workbench v.4.5.1 (CLCBio, Denmark) with a quality score limit of 0.01. All reads resulting in less than 35 bp in length were discarded. The de novo assembly of the PE reads was performed using both the CLC Genomics Workbench and ABySS v. 1.2.7 (Simpson et al. 2009 ) (k = 47 and n = 10). Default parameters were used for assembly in CLC except that the size range (minimum and maximum) between the PE reads was adjusted to 100-600 bp. The resulting contigs from CLC and ABySS were merged into one set of contigs using Minimus from the AMOS software package (Sommer et al. 2007 ). Finally, the annotation of the genome was determined by uploading the contigs into RAST (Rapid Annotations using Subsystem Technology) server (Aziz et al. 2008 ) and structural rRNAs and tRNAs were determined using RNAmmer and tRNAscan-SE (Lagesen et al. 2007 ).
Results
In this study a bacterial strain (I11) isolated from activated sludge capable of degrading ibuprofen was subjected to quantitative proteomics, characterizing the relative changes in the proteome associated with growing this strain in the presence/absence of ibuprofen.
Strain I11 did not grow on ibuprofen as a sole source of carbon and energy (data not shown). However, simultaneous growth and degradation of ibuprofen was observed on M9 medium supplemented with yeast extract and tryptone at different initial ibuprofen concentrations and in OD2-medium (Fig. 3) .
The effect of the initial concentration of ibuprofen on the degradation by I11 revealed that after 300 h the concentration of the parent compound was reduced 28 and 50 % when grown in M9 media with 1,000 and 250 lg/L, respectively. A reduction of 62 and 92 % after 90 h was observed on M9 medium and OD2-medium, respectively, for the initial ibuprofen concentration of 50 lg/L.
Metabolic labelling of this isolate with 15 N, using a forward/reverse labelling strategy, was applied yielding biological duplicates (see Fig. S1 in the supplemental material). Ibuprofen degradation always followed a linear degradation throughout the first 30 h. To avoid Patulibacter sp. I11 entering stationary growth phase, all incubations were carried out until the mid-logarithmic growth phase (OD 600 * 0.6).
Whole-genome sequencing
To increase the efficiency of the MS-based protein identification, which is known to decrease as amino acid divergence between measured peptides and database entries increases (VerBerkmoes et al. 2009 ), whole-genome sequencing of I11 was carried out. The assembly resulted in a total of 358 contigs with total 173,723,517 reads; 2,000 fold coverage; mean read length 64 bp and an N50 contig length of 24.7 kb. The uncompleted draft genome included 5,093,141 bases (5.1 Mb) and comprised 4,408 predicted coding sequences (CDSs), with a G?C content of 74 %. Among the 4,408 predicted protein coding sequences, 1,387 (31.4 %) were of unknown function. The retrieved assembled genome was annotated by RAST (Aziz et al. 2008 ) using sequence-based comparison against genome database of Conexibacter woesei (CP001854), closest phylogenetic sequenced genome available with the highest protein similarity with I11. A comparative alignment with 16S rRNA gene sequences showed that this strain had a 96 % similarity with P. minatonensis (AB193261). This Whole-genomeShotgun project has been deposited at DDBJ/EMBL/GenBank under the accession AGUD00000000. The version described in this paper is the first version, AGUD01000000.
Quantitative proteome analysis of ibuprofen degrading bacteria The 14 N-and 15 N-labelled cells were harvested, lysed and fractionated into a cytosolic and a membrane fraction and mixed in accordance with the forward/ reverse labelling strategy and separated by SDS-PAGE. No major differences were evident by direct visualization when comparing the isolate grown under the two different sets of conditions (Fig. 4) .
For each of the two biological replicates (forward and reverse labelling experiment) the membrane and the cytosolic fraction were nested following statistical analysis. In total, 251 unique proteins, identified and quantified, were found to be statistically significant (p \ 0.05). Of these 251 proteins, 99 proteins were shared between the forward and the reverse labelling experiments, when both biological replicates were considered (Fig. S2) . 73 proteins were exclusively present in the forward labelling experiment whereas 79 proteins were exclusive to the reverse labelling experiment (Fig. S2) . For all of the 251 quantified proteins, full length protein sequences retrieved from functionally annotated genome of Patulibacter sp. strain I11 were blasted against the UniRef100 database, yielding the closest protein homologue. Proteins (closest homologues) were categorized based upon Gene Ontology Categories (GOC) revealing similar distributions between the forward and reverse labelling experiments (Fig. S2 ).
Up-regulated proteins in the presence of ibuprofen
Comparative analysis revealed that in total, 72 proteins (nesting forward and reversed labelled replicates) were differentially up-regulated, i.e. defined as having a log2 ratio above 0.9, in response to ibuprofen feeding. Of these 72 proteins, 64 were unique. Out of the 64 unique up-regulated proteins, 12 were observed in both the forward and the reverse labelling experiment (Fig. S3 A) . 25 proteins were exclusive to the forward labelling experiment whereas 15 were exclusive to the reverse labelling experiment.
Proteins were functionally characterised using 3 levels of Gene Ontology: biological process, molecular function and cellular component. ''Cellular processes'' was found to be the predominant biological process, with 75 % of the GO annotated proteins falling within this category. 44 % of these proteins were annotated as being associated with the ribosome. As for molecular function annotation, ''Binding'' and ''Catalytic activity'' accounted for 40 and 38.3 % of the GO annotated proteins, respectively.
Proteins which had a log2 ratio above 1.5 were dominated by putative uncharacterized proteins. In an attempt to elucidate potential biological relevance of these proteins, function prediction was attempted by blasting the sequences of the hypothetical proteins of Patulibacter sp. strain I11 against the UniRef100 database, using UniProt BLAST. However, no function could be inferred based upon protein homology, with this approach. Function prediction was also attempted with ProtFun 2.2 (http://www.cbs.dtu.dk/ services/ProtFun/), a tool that performs ab initio prediction based upon sequence. Of the total uncharacterized up-regulated proteins, D3FA23 was predicted as having a possible lyase function and D3F6B1 as a possible stress response protein (Table S2 ). The tool used for the prediction was developed for eukaryotic cells and was expected to have a lower accuracy of prediction for prokaryotes. However, it has been demonstrated that the tool performs better on prokaryotes than expected, and is able to yield meaningful results (Jensen et al. 2002) . Within the group of proteins categorized as being involved in metabolic processes, several proteins related to the degradation of aromatic hydrocarbons were identified. A number of proteins were highly upregulated in response to ibuprofen feeding (log2 ratio [1.5): Aminotransferase class III (E6SEB9), acyl-CoA synthase (AMP-forming) (J2XUN5), protein containing a Rieske (2Fe-2S) iron-sulphur domain (D3F3V3), enoyl-CoA hydratase/isomerase (D3F114), nuclear export factor GLE1 (D3F2P4) as well as several uncharacterised proteins (Table 1) . Proteins involved in catalytic processes represented an abundant group of up-regulated proteins with a possible correlation with ibuprofen degradation and were composed of cytochrome b and c, several dehydrogenases and oxidoreductases (Table 1) . Proteins involved in fatty-acid metabolism and energy metabolism were found to be up-regulated as well, and are possibly related to energy gain response. Growing the isolate I11 in the presence of 65 lg/L of ibuprofen does not appear to have triggered a cellular stress response; only two proteins related to stress stimulus, the 60 kDa chaperonin (D3F2T2) and the predicted stress response protein (D3F6B1), were found up-regulated.
Several proteins related to the up-take and degradation of other aromatic acids (i.e. benzoate and phenylacetic acid) were found up-regulated in the presence of ibuprofen: enoyl-CoA hydratase/isomerase (D3F114), acyl-CoA synthetase (AMP-forming) (J2XUN5) and Rieske (2Fe-2S) iron-sulphur domain protein (D3F3V3). Similarly proteins related to transport and binding of extracellular compounds were upregulated in the presence of ibuprofen and might be related to the uptake of this compound: ABC-2 type transporter (D3FBI2), daunorubicin resistance ABC transporter ATPase (D3FBI3) and an extracellular solute-binding protein type 1 family (D3FBH9).
Down-regulated proteins in the presence of ibuprofen
Proteome analysis revealed the down-regulation of a total of 103 proteins of which 96 proteins were unique; 35 and 27 were exclusive to the forward and reverse labelling experiment, respectively; 17 were common to both (Fig. S3 B) .
The majority of these proteins are related to binding of extracellular compounds (41 %) and catalytic activities inside the cell (41 %). The most prominent down-regulated proteins, with a log2 ratio between -4 and -1. 
Genomic analysis
The genome sequence of Patulibacter sp. strain I11 was analyzed for the presence of putative orthologous genes known to be involved in aromatic acid degradation. The focus was on those previously hypothesized to be involved in the biodegradation of ibuprofen (Kagle et al. 2009 ) and in two other structurally similar aromatic hydrocarbons, phenylacetic acid (Ferrandez et al. 1998 ) and benzoate (Craven et al. 2009 ). Sphingomonas strain Ibu-2 was previously isolated from activated sludge and characterized for its ability to use ibuprofen as a sole carbon source (Kagle et al. 2009 ). In that study, genetic and biochemical analysis revealed a cluster of genes (ipfABDEF) that were proposed to be involved in ibuprofen catabolism. A search in the strain I11 genome revealed five orthologous genes whose products share 33-46 % amino acid sequence similarity with those found in Sphingomonas Ibu-2 (Table 3 ). Only one of these genes, ipfF, which sharing 33 % amino acid similarity, was found to be up-regulated in this study encoding for acyl-CoA synthetase (AMP-forming) (J2XUN5). Interestingly, a protein containing a Rieske (2Fe-2S) iron-sulphur domain (D3F3V3) was found up-regulated in ibuprofen-grown cells sharing similar annotated function (dioxygenase) to the protein encoded by ipfA.
In the same line, Acinetobacter strain ADP1 was shown to degrade benzoate as the sole carbon source (Craven et al. 2009 ). Two clusters of genes, ben genes (benABCDEKPM) and cat genes (catABCDFIJM) have been described to be involved in the metabolism of aromatic hydrocarbons including benzoate (Craven et al. 2009 ). Protein blast of the two clusters of genes against the predicted proteome of Patulibacter sp. I11 yielded a 24-43 % identity (Table S3) .
Finally, 13 catabolic enzymes (paaABCEFGHIJK-LMN) were reported in the aerobic degradation of phenylacetic acid in E. coli strain-K12 (Ferrandez et al. 1998) . Fifteen of the genes encoding these enzymes were recognized in the Patulibacter sp. I11 genome with 25-54 % amino acid sequence identity (Table S3 ).
Transcription analysis
Incubation of I11 in OD2-medium under the same conditions used for the proteomic approach was conducted to analyse an early response in ibuprofen induction genes. qPCR was employed in order to confirm the proteomic data and to investigate to which extent the ibuprofen up-regulated proteins found in this study correlated with its transcript levels. Transcript levels of the six genes encoding proteins whose levels appeared to increase in the presence of ibuprofen in the differential proteomic approach and the ipf genes previously proposed to be involved in ibuprofen degradation (Kagle et al. 2009 ) were measured (Tables 2, 3 ). Based on the change in transcript levels prior to addition of ibuprofen and 1 h after ibuprofen addition to the medium positive correlations were observed for 5 of the 6 chosen target genes (Table 2) . These positive correlations were corrected for sampling and analysis biases by adjusting to the levels of I11-16S rRNA gene and the increase in fold was found to range between 1.21 ± 0.10 and 1.60 ± 0.14 (n = 3). Negative correlation was observed only for f Fold change in target gene relative to untreated as measured by qPCR and analysed using the CT method D3F3VE (-1.49 ± 0.09; n = 3). Elevated transcript levels were detected for the 4 of the 5 tested ipf genes with a fold increase ranging from 1.53 ± 0.12 to 2.9 ± 0.16 (n = 3) (Table 3) . Interestingly, only IpfF that shared 51 % amino acid similarity with J2XUN5 (up-regulated at the proteome level) was not upregulated at the transcript level. None of the other ipf gene products were detected at the proteome level in this study.
Discussion
This work describes the first characterization of the changes in the proteome of a bacterial strain isolated from activated sludge in response to ibuprofen degradation, using a combination of genomic and proteomic techniques. A pure culture of Patulibacter sp. strain I11 was obtained from activated sludge and showed capable of degrading ibuprofen in M9 medium supplemented with another carbon source and in rich media such as OD2-medium under different initial concentrations of ibuprofen with up to 92 % removal within 90 h. Using isotopic labelling relative quantification of protein expression levels in the presence/absence of ibuprofen was carried out. Metabolic labelling incubations were carried out at the mid-logarithmic growth phase with similar ibuprofen reduction in all tested cultures. Comparison of the proteomes obtained from the exponential growth stage ensured that events related to oxidative stress, cell lysis and death were kept at a minimum. In the present study, only a few stress-related proteins were identified.
The genome of the isolate I11 was sequenced and used as a reference sequence for identifying proteins from the MS data. The closest related genome available to this strain was from C. woesei (CP001854), which was used in the genome annotation. Sequence analysis of the 16S rRNA gene of this isolate revealed a 96 % similarity with P. minatonensis (AB193261). C. woesei and P. minatonensis are both gram-positive soil-isolated members of the class Actinobacteria. Other ibuprofen degrading microorganisms found in literature are the proteobacterial Sphingomonas Ibu-2 (Murdoch and Hay 2005) and the actinobacterial Nocardia sp. (Chen and Rosazza 1994) although the latter does not grow on ibuprofen. Interestingly, this was the first time that a member of the genus Patulibacter was isolated from activated sludge and reported as being able to remove ibuprofen.
A sub-fractionation of the soluble (cytosolic proteins) and non-soluble (membrane proteins) protein fractions was carried out prior to 1D-gel based shotgun-proteomics in order to increase proteome coverage and resolution. In total 251 unique proteins were identified and quantified, corresponding to an Table 3 Transcript levels of Patulibacter sp. I11 genes, homologous to Sphingomonas Ibu-2 ipf genes (ipfABDEF) previously proposed to be involved in ibuprofen degradation (Kagle et al. 2009) (Nadeau et al. 2003) . Proteins related to metabolism of ibuprofen may not be among the most abundant proteins and might therefore lead to difficulties in identifying some of the proteins involved in ibuprofen degradation pathway. Nevertheless, among the quantified and identified proteins, several are likely to be involved in ibuprofen degradation. Some of these proteins were identified as having a possible role in the actual degradation whereas others are likely related to the ibuprofen uptake mechanism. Most notably, proteins that are related to the degradation of aromatic hydrocarbons (e.g. phenylacetic acid and benzoate) were up-regulated in the presence of ibuprofen. General consensus was observed between the upregulated proteins found in the proteomic analysis and the transcript levels of the corresponding genes as estimated by qPCR. Among these proteins is an AMP-forming synthetase that is known to be essential for the aerobic catabolism of aromatic hydrocarbons in other microorganisms, such as Pseudomonas putida U (Luengo et al. 2007; Martinez-Blanco et al. 1990 ). This type of enzyme is commonly involved in the first step of CoA-dependent degradation pathway, catalysing the formation of an acyl-CoA ester with the release of AMP (Pérez-Pantoja et al. 2009 ). In the present study, acyl-CoA synthetase (AMP-forming) (J2XUN5) was up-regulated in the presence of ibuprofen with a log2 ratio of 2.35, as suggested earlier in the ibuprofen degradation pathway by Sphingomonas Ibu-2 (Kagle et al. 2009 ), which strongly indicates that it has a similar role in Patulibacter sp. strain I11. However, qPCR results indicated that the orthologous gene ipfF in I11 is not up-regulated at the transcription level. Thus it is not possible to conclude if the acyl-CoA synthetase (J2XUN5) found up-regulated in this study is involved in ibuprofen degradation and further studies are needed to address this question. Similarly, one protein containing a Rieske (2Fe-2S) iron-sulphur domain was up-regulated in the presence of ibuprofen, having a log2 ratio of 1.4. Several Rieske-domain containing proteins are well known for participating in the initial oxidation of aromatic ring structure by the addition of dioxygen. Bacterial hydrocarbon dioxygenases, are an example of proteins that belong to a large family of Rieske non-heme iron oxygenases (Gibson and Parales 2000; Pérez-Pantoja et al. 2009 ). However, the qPCR results did not confirm an increase of this gene in response to ibuprofen degradation. Lastly, enoylCoA hydratase/isomerase was highly up-regulated; this enzyme is well known for catalysing the hydroxylation of double bonds after the opening of the aromatic ring (Pérez-Pantoja et al. 2009 ). In the case of phenylacetic acid catabolism by E. coli and Pseudomonas U, an ortholog to this enzyme was shown to be involved in the last step of the catabolic pathway of this aromatic compound (Pérez-Pantoja et al. 2009; Luengo et al. 2007 ).
The overall up-regulation of the described catalytic proteins might suggest a similar transformation of ibuprofen and ibuprofen metabolites by Patulibacter sp. strain I11. Besides the actual degradation, several proteins potentially associated with the uptake of the compound were up-regulated in response to ibuprofen. An ABC transporter related protein, which is likely to be involved in the uptake of ibuprofen, was observed to be up-regulated as a response to ibuprofen presence. The uptake of ibuprofen is the initial step necessary for its degradation, and previous reports have shown that ABC transporter related proteins, cytochromes and NADH-dehydrogenases were up-regulated in cells grown on aromatic hydrocarbons such as benzoate by Corynebacterium glutamicum (Haussmann et al. 2009 ) and Pseudomonas strain KT2440 (Yun et al. 2011) , phenol by Pseudomonas strain KT244 (RomaRodrigues et al. 2010 ) and 4-chlorophenol by Pseudomonas (Cao and Loh 2009) .
In an attempt to complement the proteomic analysis, the genome of Patulibacter sp. strain I11 was studied in relation to the degradation of ibuprofen by Sphingomonas Ibu-2 (Kagle et al. 2009 ) and by other aromatic hydrocarbons.
Benzoate and phenylacetic acid degradation were well described in other studies and were used as model compounds in several studies focusing on aromatic degradation (Ferrandez et al. 1998; Loh and Cao 2008; Luengo et al. 2007; Patrauchan et al. 2005) . Some of the proteins described in this work shared similar functions with the proteins involved in the degradation of such compounds. For this reason Patulibacter sp. strain I11 genome was also screened for genes involved in the degradation of benzoate and phenylacetic acid, which share structural similarity to ibuprofen. The presence of these genes in I11 genome could potentially reveal the versatility of this organism towards the degradation of other aromatic compounds. Similar genes were detected that account for the degradation of benzoate by Acinetobacter strain ADP1 (Craven et al. 2009 ), phenylacetic acid by E. coli K12 (Ferrandez et al. 1998 ) and ibuprofen by Sphingomonas Ibu-2 (Kagle et al. 2009 ), but having different percentages of similarity. I11 are phylogenetically distinctly related to previously described ibuprofen degraders, and this could account for the low protein similarity to ipf genes previously proposed to be involved in ibuprofen degradation. The most similar genes among this set of genes detected in Patulibacter sp I11 were the ones described for the degradation of benzoate. A proteome search for the expression of the genes proposed to be responsible for the degradation of ibuprofen in Sphingomonas Ibu-2 (Kagle et al. 2009 ) revealed that only the IpfF, was expressed. This protein (J2XUN5) shares 51 % identity with IpfF from Sphingomonas sp. Ibu-2. However, the transcription of this gene was not induced by the presence of ibuprofen by I11. The ipfABDE genes were not found upregulated at proteomic level but were induced by I11 in the presence of ibuprofen. The expression of these genes by I11 and its previous report in ibuprofen degradation by Sphingomonas sp. Ibu-2 supports the possible involvement of these enzymes in ibuprofen degradation by Patulibacter sp. strain I11.
The differences observed between the proteomic data and the qPCR data, with the negative correlation for D3F3VE and the positive results for the expression ipf genes, could be explained partly by fundamental biological differences between the transcription and translation processes, and/or by experimental challenges and the relative low coverage in the proteome (Hegde et al. 2003) .
The abundance of putative uncharacterized proteins among the up-regulated proteins illustrates the extent of novelty within functionally important individual proteins, and possibly entire cellular processes/pathways involved in ibuprofen degradation. Four orthologous genes proposed to be involved in the degradation of ibuprofen by Sphigomonas sp. Ibu-2 was also found to be present and expressed in response to the presence of ibuprofen in Patulibacter sp. I11. Verification of role of the identified proteins requires further analysis such as expression studies and protein characterization.
In summary, this work clearly represents novel information regarding the cellular response of an ibuprofen-degrading microorganism to this important NSAID. The Patulibacter sp. described here is the first gram positive isolate with a demonstrated ability to degrade ibuprofen. A number of proteins were identified and found to be up-regulated in the presence of low levels of ibuprofen. These proteins constitute potential candidates that may be involved in enzymatic degradation pathways for the micropollutant ibuprofen. The details of such pathway(s) and how they are regulated in situ, for the biodegradation of this important micropollutant, remain largely unknown. This study demonstrates the value of such a genomic and proteomic approach in providing a better understanding of ibuprofen biodegradation in the environment and in wastewater treatment systems.
